Patient Capital in the Age of the $10B Seed | Brian Smith, S3 Ventures

Patient Capital in the Age of the $10B Seed | Brian Smith, S3 Ventures

January 21, 2026 · 52 min · Episode 170

About this episode

Brian Smith discusses the current venture market and the advantages of small funds in the age of high seed valuations.

The current venture market is defined by a dangerous decoupling of capital from reality. While the industry chases $10B seed valuations and trillion-dollar infrastructure bets, Brian Smith and S3 Ventures are executing a "Discipline Arbitrage." They argue that the real returns in AI will not come from the massive CapEx spenders, but from the application layer that solves boring, regulated, enterprise problems. This episode audits the structural risks of the current AI wave and explains why staying as a small fund may be the ultimate competitive advantage. Agenda 01:30 Cisco Moment & 28 Bellagios 06:31 Applications First, Agents Next 19:06 2021 Bubble vs 2025 Reality 32:55 Defining Patient Capital 44:09 Strategic Advantage of Small Funds 53:03 Return to Atoms Guest Links Brian Smith , S3 Ventures ( Website , X , LinkedIn ) ------------------- Austin Next Links: Website , X/Twitter , YouTube , LinkedIn Ecosystem Metacognition Substack

People in this episode

Host: Jason Scharf

Guest: Brian Smith

Topics covered

Keywords

Mentioned in this episode

Organizations: S3 Ventures, Cisco, AI

More episodes of Austin Next

Explore listener stats, chart rankings, contacts and more on the Austin Next podcast page.